Reflector

What to make of the simmering public and political angst

With a new Commission looming, here’s who’s vying for the top spot in shaping EU strategy, including key questions in pharma.

European industry fights over every inch on comparative drug pricing initiative.

Europe slow to action on emerging technologies, but the complex issues clouding EHRs and gene editing, for example, offer pause.